Latest Scleroderma Stories
Decision Marks Delay in Potential First Treatment for Deadly Disease SAN JOSE, Calif., May 4 /PRNewswire-USNewswire/ -- The Coalition for Pulmonary Fibrosis (CPF), representing tens of thousands of patients, is responding to the news that the FDA chose to ask for further study of Pirfenidone, which will delay potential approval of the first drug in the treatment of Pulmonary Fibrosis (PF), a lethal lung disease that is irreversible, progressive and deadly in an average of three years.
DANVERS, Mass., May 4 /PRNewswire-USNewswire/ -- The Scleroderma Foundation announces an open call for proposals for its 2011 Research Grant Program.
SOUTH SAN FRANCISCO, Calif.
SOUTH SAN FRANCISCO, Calif., April 22 /PRNewswire/ -- Actelion Pharmaceuticals US, Inc.
By studying the genetics of a rare inherited disorder called stiff skin syndrome, researchers at the Johns Hopkins University School of Medicine have learned more about scleroderma, a condition affecting about one in 5,000 people that leads to hardening of the skin as well as other debilitating and often life-threatening problems.
SAN DIEGO, Feb. 10 /PRNewswire/ -- Amira Pharmaceuticals, Inc. announced today that their collaborators, Andrew Tager, M.D. and Flavia V. Castelino, M.D.
DANVERS, Mass., Nov. 16 /PRNewswire-USNewswire/ -- For an estimated 5-10 percent of the population, the wintertime blues are more than a state of mind.
At its most benign, the autoimmune disease scleroderma can discolor parts of the skin of its sufferers. At its most pernicious, it can thicken and harden their skin, their blood vessels, and their internal organs before, in many cases, killing them.
Honoring Congresswoman Linda T. Sanchez (CA) and Actress Kellie Martin Gala to raise funds for the Scleroderma Foundation, Southern California Chapter LOS ANGELES, Oct.
Investigators have identified a drug that is currently approved to treat certain types of cancer, Gleevec, that could provide the first treatment for scleroderma, a chronic connective tissue disease for which a treatment has remained elusive.
- A political dynamiter.